On Fullscript, whole person care flows seamlessly to help you capture clear context, recommend quality products, and keep patients engaged in their plan
AOD 9604 is known for helping with weight management and metabolism
Henry RR, Thakkar P, Tong C, Polidori D, Alba M (2015) Efficacy and safety of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to insulin in patients with type 1 diabetes
Gastrointestinal issues (nausea, vomiting, constipation) can result from the use of both semaglutide and tirzepatide
Due to its much shorter half-life (8 hours to 15 hours) than warfarin (20 hours to 40 hours), bleeding events, if not critical, were previously reversed by medically supervised cessation of the drug, hemodialysis, or local measures such as activated charcoal
Avoid use if you have severe kidney disease or are on dialysis unless closely supervised by a nephrologist